Targeting M6A dysregulation in ALS via small molecule approaches

Active Project Grant Awarded Last action

Award ID
HT9425261E032
Recipient
Awarding agency
Obligated
$840,000

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 17% complete
Place of performance
Phoenix, AZ 85013, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Defense Health Agency awarded Barrow Neurological Institute at ST. Joseph's Hospital and Medical Center $840,000 on July 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to investigate M6A dysregulation in amyotrophic lateral sclerosis via small molecule therapeutic approaches. Research is conducted in Phoenix, Arizona, with a period of performance through June 30, 2028. The award is classified as a Project Grant, a sub-program within the Defense Health Program supporting basic, applied, and advanced biomedical research to transform health care for Service Members and the American public through innovative and impactful research and investigation of medical solutions for the battlefield.

Subawards

Subrecipient Amount Awarded
Arizona State University ASU has iPSC samples that were previously sourced from the NIH IPSC repository (https:// nindsgenetics.org/), and are available for secondary use. ASU will… $140,000

Quick answers

Who received award HT9425261E032?

HT9425261E032 was awarded to Barrow Neurological Institute At ST. Joseph's Hospital And Medical Center by Defense Health Agency (Department of Defense) on July 1, 2026.

How much is award HT9425261E032 worth?

$840,000 has been obligated on HT9425261E032.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login